N/A N=55 Single-blind Basic Science

Oxytocin Pathways and the Health Effects of Human-Animal Interaction

Human-Animal Bond · Human-Animal Interaction

Bottom Line

View on ClinicalTrials.gov: NCT03852264 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2024

Primary outcome: Primary: Salivary Oxytocin, Area Under the Curve — -3.03; -3.83; -5.57 pg/mL x minutes

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Pet dog (Behavioral); Unfamiliar dog (Behavioral); Nonsocial control (Behavioral)
Age: Pediatric · 8+ yrs
Sex: All
Sponsor: University of Arizona
Primary completion: Jan 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Salivary Oxytocin, Area Under the Curve	-3.03; -3.83; -5.57	—
PRIMARY Urinary Oxytocin, Area Under the Curve	0.261; -0.219; -0.180	—
SECONDARY Salivary Cortisol, Area Under the Curve	-99.7; -221.1; -103.0	—
SECONDARY Urinary Vasopressin, Area Under the Curve	—	—

Summary

This study investigates the roles of oxytocin pathways in human-animal interaction.

Eligibility Criteria

Inclusion Criteria

Participants in this study will include typically-developing children between 8-10 years who have lived with a companion dog in the household for at least 6 months.

Exclusion Criteria

known medical diseases or injuries involving the central nervous or endocrine systems, major physical abnormalities, seizures, and significant sensory, cognitive, or motor impairments, current use of psychoactive medications

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03852264). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.